DNAJC5 and infection: Further characterization of the (fine) specificity of these functional non-CSP antibodies and their relative contribution to protection will contribute to a better understanding of antibody-mediated protection after natural infection or Pf-sporozoite immunization and will accelerate clinical development of protective vaccines and/or mAbs.